AV
Schedule 13D filing
ARCH Venture Fund XII, L.P. disclosed a 25.6% stake in CTY
ARCH Venture Fund XII, L.P. reported owning 25.6% of City Therapeutics, Inc. (CTY) (13,692,507 shares) in a Schedule 13D filed Oct 26, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Oct 26, 2026
- Source
- Schedule 13D
More CTY insider and Congress trades
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.